| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Medical Research Center for Cancer Molecular Therapy and Department of Biochemistry, College of Medicine, Dong-A University, Busan, Korea;
Department of Pharmacology, University of Illinois, Chicago, IL 60612; and
Division of Molecular and Life Sciences, Pohang University of Science and Technology, Pohang, Korea
Formyl peptide receptor-like 1 (FPRL1) is an important classical chemoattractant receptor that is expressed in phagocytic cells in the peripheral blood and brain. Recently, various novel agonists have been identified from several origins, such as host-derived molecules. Activation of FPRL1 is closely related to inflammatory responses in the host defense mechanism and neurodegenerative disorders. In the present study we identified several novel peptides by screening hexapeptide libraries that inhibit the binding of one of FPRL1’s agonists (Trp-Lys-Tyr-Met-Val-D-Met-CONH2 (WKYMVm)) to its specific receptor, FPRL1, in RBL-2H3 cells. Among the novel peptides, Trp-Arg-Trp-Trp-Trp-Trp-CONH2 (WRWWWW (WRW4)) showed the most potent activity in terms of inhibiting WKYMVm binding to FPRL1. We also found that WRW4 inhibited the activation of FPRL1 by WKYMVm, resulting in the complete inhibition of the intracellular calcium increase, extracellular signal-regulated kinase activation, and chemotactic migration of cells toward WKYMVm. For the receptor specificity of WRW4 to the FPR family, we observed that WRW4 specifically inhibit the increase in intracellular calcium by the FPRL1 agonists MMK-1, amyloid 
42 (A42) peptide, and F peptide, but not by the FPR agonist, fMLF. To investigate the effect of WRW4 on endogenous FPRL1 ligand-induced cellular responses, we examined its effect on A42 peptide in human neutrophils. A42 peptide-induced superoxide generation and chemotactic migration of neutrophils were inhibited by WRW4, which also completely inhibited the internalization of A42 peptide in human macrophages. WRW4 is the first specific FPRL1 antagonist and is expected to be useful in the study of FPRL1 signaling and in the development of drugs against FPRL1-related diseases.
This article has been cited by other articles:
|
|
 |
|
  C. Prat, P.-J. Haas, J. Bestebroer, C. J. C. de Haas, J. A. G. van Strijp, and K. P. M. van Kessel A Homolog of Formyl Peptide Receptor-Like 1 (FPRL1) Inhibitor from Staphylococcus aureus (FPRL1 Inhibitory Protein) That Inhibits FPRL1 and FPR J. Immunol., November 15, 2009; 183(10): 6569 - 6578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Kim, J. M. Kim, S. H. Jo, H. Y. Lee, S. Y. Lee, J. W. Shim, S.-K. Seo, J. Yun, and Y.-S. Bae Functional Expression of Formyl Peptide Receptor Family in Human NK Cells J. Immunol., November 1, 2009; 183(9): 5511 - 5517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Ye, F. Boulay, J. M. Wang, C. Dahlgren, C. Gerard, M. Parmentier, C. N. Serhan, and P. M. Murphy International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family Pharmacol. Rev., June 1, 2009; 61(2): 119 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bjorstad, G. Askarieh, K. L. Brown, K. Christenson, H. Forsman, K. Onnheim, H.-N. Li, S. Teneberg, O. Maier, D. Hoekstra, et al. The Host Defense Peptide LL-37 Selectively Permeabilizes Apoptotic Leukocytes Antimicrob. Agents Chemother., March 1, 2009; 53(3): 1027 - 1038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Y. Lee, S. D. Kim, J. W. Shim, S. Y. Lee, H. Lee, K.-H. Cho, J. Yun, and Y.-S. Bae Serum Amyloid A Induces CCL2 Production via Formyl Peptide Receptor-Like 1-Mediated Signaling in Human Monocytes J. Immunol., September 15, 2008; 181(6): 4332 - 4339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. El Kebir, L. Jozsef, and J. G. Filep Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation J. Leukoc. Biol., September 1, 2008; 84(3): 600 - 606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. A. Schepetkin, L. N. Kirpotina, J. Tian, A. I. Khlebnikov, R. D. Ye, and M. T. Quinn Identification of Novel Formyl Peptide Receptor-Like 1 Agonists That Induce Macrophage Tumor Necrosis Factor {alpha} Production Mol. Pharmacol., August 1, 2008; 74(2): 392 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Berkestedt, A. Nelson, and M. Bodelsson Endogenous antimicrobial peptide LL-37 induces human vasodilatation Br. J. Anaesth., June 1, 2008; 100(6): 803 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. El Zein, B. Badran, and E. Sariban VIP differentially activates {beta}2 integrins, CR1, and matrix metalloproteinase-9 in human monocytes through cAMP/PKA, EPAC, and PI-3K signaling pathways via VIP receptor type 1 and FPRL1 J. Leukoc. Biol., April 1, 2008; 83(4): 972 - 981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Bjorkman, J. Karlsson, A. Karlsson, M.-J. Rabiet, F. Boulay, H. Fu, J. Bylund, and C. Dahlgren Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1 J. Leukoc. Biol., February 1, 2008; 83(2): 245 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Christenson, L. Bjorkman, C. Tangemo, and J. Bylund Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7-sensitive pathway independent of formyl peptide receptor-like 1 J. Leukoc. Biol., January 1, 2008; 83(1): 139 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Zhou, S. Zhang, M. Nanamori, Y. Zhang, Q. Liu, N. Li, M. Sun, J. Tian, P. P. Ye, N. Cheng, et al. Pharmacological Characterization of a Novel Nonpeptide Antagonist for Formyl Peptide Receptor-Like 1 Mol. Pharmacol., October 1, 2007; 72(4): 976 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. M. Keane, K. G. Dodds, A. M. Crawford, and J. C. McEwan Transcriptional profiling of Ovis aries identifies Ovar-DQA1 allele frequency differences between nematode-resistant and susceptible selection lines Physiol Genomics, August 20, 2007; 30(3): 253 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhao, S. Zhou, and C.-K. Heng Impact of Serum Amyloid A on Tissue Factor and Tissue Factor Pathway Inhibitor Expression and Activity in Endothelial Cells Arterioscler Thromb Vasc Biol, July 1, 2007; 27(7): 1645 - 1650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Prat, J. Bestebroer, C. J. C. de Haas, J. A. G. van Strijp, and K. P. M. van Kessel A New Staphylococcal Anti-Inflammatory Protein That Antagonizes the Formyl Peptide Receptor-Like 1 J. Immunol., December 1, 2006; 177(11): 8017 - 8026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-S. Lee, S.-A. Yoo, C.-S. Cho, P.-G. Suh, W.-U. Kim, and S. H. Ryu Serum Amyloid A Binding to Formyl Peptide Receptor-Like 1 Induces Synovial Hyperplasia and Angiogenesis J. Immunol., October 15, 2006; 177(8): 5585 - 5594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Barlow, Y. Li, T. S. Wilkinson, D. M. E. Bowdish, Y. E. Lau, C. Cosseau, C. Haslett, A. J. Simpson, R. E. W. Hancock, and D. J. Davidson The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system J. Leukoc. Biol., September 1, 2006; 80(3): 509 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Babbin, W. Y. Lee, C. A. Parkos, L. M. Winfree, A. Akyildiz, M. Perretti, and A. Nusrat Annexin I Regulates SKCO-15 Cell Invasion by Signaling through Formyl Peptide Receptors J. Biol. Chem., July 14, 2006; 281(28): 19588 - 19599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kim, B. D. Lee, O. Kim, Y.-S. Bae, T. Lee, P.-G. Suh, and S. H. Ryu Pituitary adenylate cyclase-activating polypeptide 27 is a functional ligand for formyl Peptide receptor-like 1. J. Immunol., March 1, 2006; 176(5): 2969 - 2975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Nagaoka, H. Tamura, and M. Hirata An Antimicrobial Cathelicidin Peptide, Human CAP18/LL-37, Suppresses Neutrophil Apoptosis via the Activation of Formyl-Peptide Receptor-Like 1 and P2X7. J. Immunol., March 1, 2006; 176(5): 3044 - 3052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Fu, J. Karlsson, J. Bylund, C. Movitz, A. Karlsson, and C. Dahlgren Ligand recognition and activation of formyl peptide receptors in neutrophils J. Leukoc. Biol., February 1, 2006; 79(2): 247 - 256. [Full Text] [PDF]
|
|
|
|
|
|
J. Karlsson, H. Fu, F. Boulay, C. Dahlgren, K. Hellstrand, and C. Movitz Neutrophil NADPH-oxidase activation by an annexin AI peptide is transduced by the formyl peptide receptor (FPR), whereas an inhibitory signal is generated independently of the FPR family receptors J. Leukoc. Biol., September 1, 2005; 78(3): 762 - 771. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
